Search
Selected Filter
Displaying 1–10 of 304 research results
-
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
Eye On the Cure Research NewsThe company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Eye On the Cure Research NewsOpus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Foundation Funds 25 New Grants Totaling $15.1 Million in FY23
Eye On the Cure Research NewsThe global leader in retinal degenerative disease research supports a total of 93 research grants in its portfolio.
-
SparingVision Recruiting for Clinical Trial of Cone-Preserving Gene Therapy for RP
Eye On the Cure Research NewsFirst cohort of patients has been dosed in Phase ½ clinical trial taking place in Pittsburgh and Paris
-
Atsena Doses First Patient in XLRS Gene Therapy Clinical Trial
Eye On the Cure Research NewsThe AAV.SPR gene delivery system used in the trial is designed to more safely reach targeted retinal cells
-
Théa Acquires ProQR’s LCA10 and USH2A Treatment Programs, Plans to Continue Clinical Development
Eye On the Cure Research NewsKnown as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
-
FDA Approves 8 MG Dosing of Eylea for Wet AMD, Diabetic Macular Edema, and Diabetic Retinopathy
Eye On the Cure Research NewsNew, higher treatment dose reduces frequency of eye injections for patients
-
IZERVAY Approved by FDA for Treatment of Geographic Atrophy Secondary to Advanced Dry AMD
Eye On the Cure Research NewsIn two Phase 3 clinical trials, IZERVAY slowed the growth rate of lesions, the regions of cell loss in the central retina, associated with geographic atrophy (GA)
-
Belite Bio Doses First Patient in Phase 3 Clinical Trial for Advanced Dry AMD (GA) Therapy
Eye On the Cure Research NewsThe company’s emerging, oral treatment is designed to slow vision loss
-
PYC Doses First Patient in Clinical Trial of RNA Therapy for RP11 (PRPF31 Mutations)
Eye On the Cure Research NewsThe emerging RNA therapy is designed to boost expression of the PRPF31 protein
.png)
.png)
